Christine Bee
10Patents
2h-index
29Co-inventors
46Inventor score
Filing activity: Jul 13, 2017 → Feb 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10077306B2 | Antibodies against TIM3 and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US10533052B2 | Antibodies against TIM3 and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US11591392B2 | Antibodies against TIM3 and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11274150B2 | Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US11981734B2 | Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A) | Emerging Cross-Sectional Technologies | 0 | Active |
| US12077584B2 | Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A) | Emerging Cross-Sectional Technologies | 0 | Active |
| US12129297B2 | Antibodies against TIM3 and uses thereof | Physics | 0 | Active |
| US10023634B2 | Antibodies against TIM3 and uses thereof | General | 0 | Revoked |
| US11401328B2 | Antibodies binding to ILT4 | Chemistry; Metallurgy | 0 | Active |
| US12312403B2 | Antibodies against TIM3 and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.